1404P Update results of paclitaxel and cisplatin in combination with anlotinib as first-line treatment for patients with advanced ESCC: A multicenter, single-arm, open-label phase II clinical trial

Autor:	T. Wu, Jyh-Shyang Wang, Y-G. Hong, N. Li, Y. Cheng, Y-Z. Guo, S-X. Luo
Rok vydání:	2021
Předmět:	Oncology Cisplatin medicine.medical_specialty business.industry Hematology First line treatment Clinical trial chemistry.chemical_compound Paclitaxel chemistry Internal medicine medicine Open label business medicine.drug
Zdroj:	Annals of Oncology. 32:S1058
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2021.08.1513
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b032145c936aa048e70f459cb296a515 https://doi.org/10.1016/j.annonc.2021.08.1513 Zobrazit plný text záznamu